TREg Activation in the Treatment of the PELADE (Alopecia Areata)
Status:
Completed
Trial end date:
2019-12-02
Target enrollment:
Participant gender:
Summary
In a prospective pilot study the investigators showed that low doses of IL2 could be
beneficial for severe AA inducing a long lasting regrowth in 4 out of the 5 patients treated.
The objective of this study is to compare the long term efficacy of low doses of IL2 versus
placebo in a multicenter prospective randomized double blind study.